Evidence map›Paper›PMID 41307714›Full record

ArticleBreast cancer research and treatment2025

Promoting Resilience in Stress Management (PRISM) for women with breast cancer: a qualitative analysis of patient impressions and recommendations.

Molly Ream, Chloe J Taub, Adam Rene Rosenbaum, Etzael Ortiz Olguin, Tanvi Padalkar, Nicole L Henderson, Jessica Shuey, Joyce P Yi-Frazier, Courtney C Junkins, Katherine Reeder-Hayes and 2 more

Abstract read
PubMed Publisher
In one paragraph

Article in Breast cancer research and treatment, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Molly ReamDana-Farber Cancer Institute, Department of Supportive Oncology, 450 Brookline Ave, Boston, MA, 02215, USA. mream@mgh.harvard.edu.ORCID http://orcid.org/0000-0002-6400-9739
Chloe J TaubDepartment of Medicine, Division of General Internal Medicine and Population Science, University of Alabama at Birmingham, Birmingham, USA.
Adam Rene RosenbaumDana-Farber Cancer Institute, Department of Pediatric Hematology and Oncology, Boston, USA.
Etzael Ortiz OlguinDepartment of Medicine, Division of Hematology Oncology, University of Alabama at Birmingham, Birmingham, USA.
Tanvi PadalkarDepartment of Medicine, Division of Hematology Oncology, University of Alabama at Birmingham, Birmingham, USA.
Nicole L HendersonO'Neal Comprehensive Cancer Center, University of Alabama at Birmingham, Birmingham, USA.
Jessica ShueyDepartment of Medicine, Division of Hematology Oncology, University of Alabama at Birmingham, Birmingham, USA.
Joyce P Yi-FrazierDana-Farber Cancer Institute, Department of Supportive Oncology, 450 Brookline Ave, Boston, MA, 02215, USA.
Courtney C JunkinsDana-Farber Cancer Institute, Department of Supportive Oncology, 450 Brookline Ave, Boston, MA, 02215, USA.
Katherine Reeder-HayesDepartment of Medicine, Division of Oncology, University of North Carolina at Chapel Hill, Chapel Hill, USA.
Gabrielle B RocqueDepartment of Medicine, Division of General Internal Medicine and Population Science, University of Alabama at Birmingham, Birmingham, USA.
Abby R RosenbergDana-Farber Cancer Institute, Department of Supportive Oncology, 450 Brookline Ave, Boston, MA, 02215, USA.

Funding

American Cancer Society TLC-23-1180714-01-TLC
6 · The paper itself

Abstract

purposeThe Promoting Resilience in Stress Management (PRISM) intervention is a brief, positive psychological skills-based intervention delivered by lay-coaches with demonstrated efficacy at decreasing distress in young adults with cancer. We recently completed a pilot trial of "PRISM for women with breast cancer" (PRISM-BC) and demonstrated feasibility. Here, we conducted qualitative analyses to better understand the experiences of women who participated in PRISM-BC.

methodsFor this single-armed, pilot study of PRISM-BC, we recruited women who were receiving chemotherapy for any stage of breast cancer. All received the PRISM intervention, including six individual, virtual sessions and access to a companion mobile app for skill practice. Following PRISM completion, participants completed a 30-60-minute semi-structured, qualitative interview. We employed coding reliability thematic analysis to identify themes, with two team members applying codes to ensure satisfactory inter-rater reliability.

resultsWomen (N=33) were on average 54.1 years old (SD=9.5); most had early stage disease (76%), identified as Black/African American (58%), and downloaded the companion app (70%). We identified four themes: 1) PRISM was helpful due to both new skill acquisition and experiential relevance; 2) The app was helpful to many, but barriers prevented use among some; 3) Both facilitators and barriers to PRISM engagement were present; 4) Opportunities exist to tailor PRISM further to the specific needs of breast cancer survivors

conclusionPRISM was well-received among women with breast cancer. Future work should examine the efficacy of PRISM in larger, controlled trials in breast oncology incorporating suggested modifications (e.g., content around medication adherence).

Indexed as

Breast NeoplasmsResilience, PsychologicalStress, PsychologicalAdultAgedFemaleHumansMiddle AgedPilot ProjectsQualitative ResearchBreast cancerPsycho-oncologyResilience

Identifiers

PMID41307714

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.